FEBS Open Bio

Scope & Guideline

Bridging gaps in knowledge with open-access scholarship.

Introduction

Welcome to your portal for understanding FEBS Open Bio, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2211-5463
PublisherWILEY
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2011 to 2024
AbbreviationFEBS OPEN BIO / FEBS Open Bio
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

FEBS Open Bio is dedicated to publishing high-quality, original research across a broad range of biological and biochemical disciplines. The journal emphasizes interdisciplinary approaches and innovative methodologies that advance our understanding of biological systems at various levels, from molecular to cellular and organismal.
  1. Biochemical and Molecular Biology:
    Research focused on the biochemical processes that underlie cellular functions, including enzyme mechanisms, metabolic pathways, and molecular interactions.
  2. Cell Biology and Physiology:
    Studies examining cellular processes, signaling pathways, and physiological responses in various cell types, including investigations into cancer biology and stem cell research.
  3. Structural Biology and Biophysics:
    Research involving the structural characterization of biological macromolecules using techniques such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy.
  4. Genomics and Transcriptomics:
    Exploration of gene expression patterns, genetic variations, and their implications for health and disease using high-throughput sequencing technologies.
  5. Microbiology and Immunology:
    Investigations into microbial biology, host-pathogen interactions, and the immune responses to infections and diseases.
  6. Biotechnology and Bioengineering:
    Research focused on the application of biological knowledge for technological advancements, including drug development, synthetic biology, and biomanufacturing.
  7. Environmental and Ecological Studies:
    Studies assessing the interactions between biological organisms and their environments, including the impact of climate change and pollution on ecosystems.
Recent publications in FEBS Open Bio highlight several emerging themes that are gaining traction within the scientific community, reflecting contemporary challenges and innovative approaches in biological research.
  1. CRISPR and Genome Editing Technologies:
    The use of CRISPR technology for genome editing is rapidly expanding, with applications ranging from gene therapy to crop improvement, reflecting its transformative potential in biology.
  2. Microbiome Research and Its Implications:
    Studies exploring the human microbiome and its role in health and disease are on the rise, highlighting the importance of microbial communities in various biological processes.
  3. Synthetic Biology and Biomanufacturing:
    Research focused on engineering biological systems for the production of biofuels, pharmaceuticals, and other valuable compounds is gaining momentum as sustainability becomes a priority.
  4. Personalized Medicine and Biomarkers:
    The identification of biomarkers for personalized treatment strategies in various diseases, especially cancer, is a growing area of interest, driven by advances in genomics and biochemistry.
  5. Cellular Mechanotransduction:
    Investigations into how cells sense and respond to mechanical stimuli are emerging as significant, particularly in the context of tissue engineering and regenerative medicine.
  6. Immunotherapy and Cancer Treatment Innovations:
    Research into novel immunotherapeutic approaches, including CAR-T cell therapy and immune checkpoint inhibitors, is rapidly advancing, reflecting a shift towards targeted cancer therapies.

Declining or Waning

While FEBS Open Bio continues to expand its scope, certain areas of research have shown a decline in publication frequency, reflecting shifts in scientific interest or advancements in methodology that may have rendered previous approaches less relevant.
  1. Classical Biochemistry Techniques:
    Research utilizing traditional biochemical methods may be declining as newer, more advanced techniques such as CRISPR and high-throughput sequencing gain popularity.
  2. Single-Cell Analysis in Non-Cancer Contexts:
    While single-cell analysis remains a hot topic in cancer research, its application in other biological contexts may be waning as focus shifts towards more integrated approaches.
  3. Basic Microbiology Studies:
    Research that does not translate into applied microbiology or clinical relevance may be declining, as journals increasingly favor studies with direct implications for health or industry.
  4. In Vivo Models of Disease:
    The reliance on in vivo models may be decreasing as alternative methods, such as organ-on-a-chip technologies and computational models, become more prominent.
  5. Studies with Limited Interdisciplinary Approach:
    Papers that do not incorporate interdisciplinary methods or collaborations may be less favored, reflecting a trend towards integrative research.

Similar Journals

FOLIA BIOLOGICA

Exploring the Frontiers of Biochemistry and Beyond
Publisher: CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINEISSN: 0015-5500Frequency: 6 issues/year

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.

Open Biology

Advancing the frontiers of life sciences.
Publisher: ROYAL SOCISSN: Frequency: 12 issues/year

Open Biology is a prestigious, interdisciplinary journal published by the Royal Society that has been paving the way in the fields of Biochemistry, Genetics and Molecular Biology, Immunology, and Neuroscience since its inception in 2011. Catering to a global audience of researchers, professionals, and students, Open Biology operates under an open access model, facilitating the unrestricted dissemination of high-quality research findings. With a current impact factor that positions its categories in the top quartile (Q1) and impressive Scopus rankings—evidencing its influence and reach—this journal serves as a vital platform for innovators and scientific inquiries aimed at advancing our understanding of life sciences. The journal's commitment to publishing cutting-edge research makes it an essential resource for those at the forefront of scientific exploration.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Illuminating the Path of Molecular Discoveries
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

Journal of Biochemistry

Elevating the discourse in biochemistry and molecular biology.
Publisher: OXFORD UNIV PRESSISSN: 0021-924XFrequency: 12 issues/year

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.

FEBS Journal

Fostering Knowledge and Innovation in Biochemical Sciences
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

Cell Reports

Unlocking Innovations in Biochemistry and Genetics
Publisher: CELL PRESSISSN: 2211-1247Frequency: 48 issues/year

Cell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.

ACTA BIOCHIMICA POLONICA

Illuminating the Path of Biochemical Innovation
Publisher: ACTA BIOCHIMICA POLONICAISSN: 0001-527XFrequency: 4 issues/year

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

Biomolecules

Illuminating the path of discovery in molecular biology.
Publisher: MDPIISSN: Frequency: 12 issues/year

Biomolecules is a prestigious, peer-reviewed journal published by MDPI that has been dedicated to advancing the field of biochemical research since its launch in 2011. With an impressive impact factor positioning it in Q1 for Biochemistry and Q2 for Molecular Biology as of 2023, this journal serves as a vital platform for disseminating high-quality research findings related to biological macromolecules, including proteins, nucleic acids, and carbohydrates. Operating as an Open Access journal, it ensures that vital research is accessible to all, furthering knowledge dissemination and collaboration within the scientific community. Located in Basel, Switzerland, the journal has established a significant presence in major academic databases, holding commendable Scopus rankings in both Biochemistry and Molecular Biology. Researchers, professionals, and students will find Biomolecules an invaluable resource for cutting-edge research, reviews, and insights in the rapidly evolving domains of biochemistry and molecular biology.

JOURNAL OF BIOLOGICAL CHEMISTRY

Pioneering Insights into Cellular Processes
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

JOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.

Annual Review of Biochemistry

Connecting Past Discoveries with Future Innovations
Publisher: ANNUAL REVIEWSISSN: 0066-4154Frequency: 1 issue/year

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.